Skip to main content

Advertisement

SpringerLink
Log in

Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

The aim of this retrospective study was to evaluate inflammation-based scoring as a prognostic factor for operable non-small-cell lung cancer (NSCLC) in elderly patients.

Methods

We collected preoperative data from 108 patients aged above 80 years with NSCLC. Inflammation-based scoring systems, including the C-reactive protein to albumin ratio (CAR) and the Glasgow prognostic score (GPS), as well as other clinicopathological factors, were evaluated as potential prognostic factors.

Results

The median patient age was 82 (range 80–93) years and the 5-year overall and disease-specific survival rates were 49.7 and 73.9%, respectively. The cut-off value for CAR was calculated using a receiver operator characteristics analysis and patients were dichotomized accordingly. Patients with a low CAR had significantly higher overall survival than those with a high CAR (<0.028; 65.2% vs. ≥0.028; 31.0%, respectively; p < 0.01). In univariate analysis, female gender, a low Charlson comorbidity index of 0 or 1 and a low CAR were significantly identified in overall survival. On multivariate analysis, a low CAR (p = 0.03, hazard ratio: 2.13, 95% confidence interval 1.074–4.295) was identified as a significant prognostic factor.

Conclusions

The preoperative CAR is a useful predictor of overall survival and could be a simple prognostic tool to help identify resectable NSCLC in elderly patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Guerra M, Neves P, Miranda J. Surgical treatment of non-small-cell lung cancer in octogenarians. Interact CardioVasc Thorac Surg. 2013;16:673–80.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Muraoka M, Oka T, Akamine S, Tagawa T, Sasaki N, Ikuta Y, et al. Surgical treatment for lung cancer in octogenarians. Surg Today. 2005;35:725–31.

    Article  PubMed  Google Scholar 

  3. Endo H, Yamamoto R, Satoh Y, Kuwano H, Nishizawa N. Risk analysis of pulmonary resection for elderly patients with lung cancer. Surg Today. 2013;43:514–20.

    Article  Google Scholar 

  4. Okami J, Higashiyama M, Asamura H, Goya T, Koshiishi Y, Sohara Y, et al. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small-cell lung cancer. Prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol. 2009;4:1247–53.

    Article  PubMed  Google Scholar 

  5. Mun M, Kohno T. Video-assisted thoracic surgery for clinical stage I lung cancer in octogenarians. Ann Thorac Surg. 2008;85:406–11.

    Article  PubMed  Google Scholar 

  6. Tanaka F, Yoneda K. Adjuvant therapy following surgery in non-small cell lung cancer (NSCLC). Surg Today. 2016;46:25–37.

    Article  CAS  PubMed  Google Scholar 

  7. Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien–Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668–85.

    Article  PubMed  Google Scholar 

  8. Chang JY, Senan S, Paul MA, Louie AV, Balter P, Groen HJM, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomized trials. Lancet Oncol. 2015;16:630–7.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Iwata T, Nagato K, Nakajima T, Suzuki H, Yoshida S, Yoshino I. Risk factors predictive of atrial fibrillation after lung cancer surgery. Surg Today. 2016;46:877–86.

    Article  PubMed  Google Scholar 

  10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373–83.

    Article  CAS  PubMed  Google Scholar 

  11. Kawashima M, Murakawa T, Shinozaki T, Ichinose J, Hino H, Konoeda C, et al. Significance of the Glasgow prognostic score as a prognostic indicator for lung cancer surgery. Interact CardioVasc Thorac Surg. 2015;21:637–43.

    Article  PubMed  Google Scholar 

  12. Templeton AJ, McNamara MG, Seruga B, Vera-Badillo FR, Aneja P, Ocana A, et al. Prognostic role of neutrophil-to-lymphocyte ration in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:1–11.

    Article  Google Scholar 

  13. Zhou X, Du Y, Huang Z, Xu J, Qiu T, Wang J, et al. Prognostic value of PLR in various cancers: a meta-analysis. PLoS One. 2014;9:e101119.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. The c-reactive protein/albumin ratio, a novel inflammation-based score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22:803–10.

    Article  PubMed  Google Scholar 

  15. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Shibuya N, Kubota K. Clinical significance of the c-reactive protein to albumin ratio for survival after surgery for colorectal cancer. Ann Surg Oncol. 2016;23:900–7.

    Article  PubMed  Google Scholar 

  16. Xu XL, Yu HQ, Hu W, Song Q, Mao WM. A novel inflammation-based prognostic score, the c-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10:e0138657.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Kim MH, Ahn JY, Song JE, Choi H, Ann HW, Kim JK, et al. The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10:e0132109.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Ishizuka M, Nagata H, Takagi K, Horie T, Kubota K. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ann Surg. 2007;246:1047–51.

    Article  PubMed  Google Scholar 

  19. Ministry of Health, Labour, and Welfare of Japan, A bridged life table 2013. Tokyo: Government of Japan; 2013. http://www.mhlw.go.jp/toukei/saikin/hw/life/life13/. Accessed 1 Feb 2016.

  20. Saito H, Noji T, Mkamura K, Tsuchikawa T, Shichinohe T, Hirano S. A new prognostic scoring system using factors available preoperatively to predict survival after operative resection of perihilar cholangiocarcinoma. Surgery. 2016;159:842–51.

    Article  PubMed  Google Scholar 

  21. Pinato DJ, Shiner RJ, Seckl MJ, Stebbing J, Sharma R, Mauri FA. Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer. Br J Cancer. 2014;110:1930–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Hwang EC, Hwang IS, Yu HS, Kim SO, Jung S II, Hwang JE, et al. Utility of inflammation-based prognostic scoring in patients given systemic chemotherapy first-line for advanced inoperable bladder cancer. Jpn J Clin Oncol. 2012;42:955–60.

    Article  PubMed  Google Scholar 

  23. Lealdini V, Trufelli DC, Da Silva FBF, Normando SRC, Camargo EW, De Matos LL, et al. Applicability of modified Glasgow prognostic score in the assessment of elderly patients with cancer: a pilot study. J Geriatr Oncol. 2015;6:479–83.

    Article  PubMed  Google Scholar 

  24. McMillan DC. The systemic inflammation-based Glasgow prognostic score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39:534–40.

    Article  PubMed  Google Scholar 

  25. Li H, Manwani B, Leng SX. Frailty, inflammation, and immunity. Aging Dis. 2011;2:466–73.

    PubMed  PubMed Central  Google Scholar 

  26. Miyazaki T, Sakai T, Tsuchiya T, Yamasaki N, Mine M, Shibata Y, et al. Assessment and follow-up of intercostal nerve damage after video-assisted thoracic surgery. Eur J Cardiothorac Surg. 2011;39:1033–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan

    Takuro Miyazaki, Naoya Yamasaki, Tomoshi Tsuchiya, Keitaro Matsumoto, Masaki Kunizaki, Ryotaro Kamohara, Go Hatachi, Ryoichiro Doi, Tomohiro Obata & Takeshi Nagayasu

Authors
  1. Takuro Miyazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Naoya Yamasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomoshi Tsuchiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Keitaro Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masaki Kunizaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ryotaro Kamohara
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Go Hatachi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ryoichiro Doi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tomohiro Obata
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Takeshi Nagayasu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Takuro Miyazaki.

Ethics declarations

Conflict of interest

We declare no competing financial conflicts of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Miyazaki, T., Yamasaki, N., Tsuchiya, T. et al. Ratio of C-reactive protein to albumin is a prognostic factor for operable non-small-cell lung cancer in elderly patients. Surg Today 47, 836–843 (2017). https://doi.org/10.1007/s00595-016-1448-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-016-1448-8

Keywords

Search

Navigation